# rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia

> clinical trial · VERIFIED · 2026-06-17

Status: NOT_YET_RECRUITING · Sponsor: Peking Union Medical College Hospital · Condition: Lower-risk Myelodysplastic Syndromes

- Company: Peking Union Medical College Hospital
- Sector: hematology
- Primary source: https://clinicaltrials.gov/study/NCT07653581

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.